Fully automated viability and toxicity screening—A reliable all‐in‐one attempt
Abstract Background The CRISPR/Cas9 technology is nowadays a common tool for genome editing to achieve new insights into, for example, diagnostics and therapeutics in cancer and genetic disorders. Cell proliferation and anticancer drug response studies are widely used to evaluate the impact of editi...
| الحاوية / القاعدة: | Cancer Medicine |
|---|---|
| المؤلفون الرئيسيون: | , , , , |
| التنسيق: | مقال |
| اللغة: | الإنجليزية |
| منشور في: |
Wiley
2024-06-01
|
| الموضوعات: | |
| الوصول للمادة أونلاين: | https://doi.org/10.1002/cam4.7392 |